UCB Australia leadership team
"For more than 20 years, UCB has supported patients across Australia. Today, our commitment to the communities we serve is stronger than ever. By keeping patients at the heart of our innovation, we focus on delivering differentiated solutions that address unmet needs for people living with epilepsy and rare epilepsy syndromes, rare neurological diseases and chronic inflammatory diseases."
Selina Clifford
General Manager
Joined UCB in 2008
"We are committed to bringing UCB’s global innovations to Australians efficiently and responsibly, working closely with the Therapeutic Goods Administration to ensure timely registration. We are passionate about bringing safe, life changing innovations to patients."
Anna Argyropoulos
Head of Regulatory, Ethics & Compliance
Joined UCB in 2006
"By leveraging global scientific expertise, we advance innovation in chronic inflammatory diseases to improve patient outcomes, including for women navigating complex family decisions. Through high-integrity partnerships with clinicians and patient advocates, we address critical challenges like delayed diagnosis and equitable access. I am immensely proud of the positive impact our team makes on the lives of Australians every day."
Francesca Bianco
Head of Immunology Patient Value Unit
Joined UCB in 2013
"Every day, our team is inspired by the patients and communities we serve. As a leadership team, we are committed to nurturing that passion by fostering an empowering culture built on trust, accountability, and shared purpose. This collective dedication has earned us recognition as an Employer of Choice by The Australian Business Awards® for two consecutive years. As Sponsor of the Health of the Planet Committee, I work closely with colleagues to ensure our operational footprint supports the long-term wellbeing of our communities from advancing lower-emission transport policies to implementing more sustainable freight solutions and strengthening community engagement initiatives."
Craig Braithwaite
Head of I2I Patient Impact Intercontinental East
Joined UCB in 2021
“At UCB, our role is grounded in a clear responsibility: to ensure that our scientific purpose translates into meaningful progress for patients living with rare and severe conditions. These diseases place an extraordinary burden on individuals, families, a nd healthcare systems, and they demand a long‑term, thoughtful approach. Our mission is to work in close partnership with the clinical community, listen carefully to patient and caregiver experience, and apply rigorous science to address areas of greatest unmet need. By doing so, we aim to deliver solutions that make a tangible difference to safety, quality of life, and long‑term outcomes for patients.”
Peter Hanna
Head of Rare & Epilepsy Patient Value Unit
Joined UCB in 2020
"Our ability to create sustainable value for patients depends on how well we work together. Strengthening our foundations through intentional ways of working, leadership alignment and a culture where inclusion and accountability go hand-in-hand enables our teams to perform at their best.
As sponsor of the Diversity, Equity and Inclusion Committee, I am committed to creating an environment where diverse perspectives are genuinely heard, individuals feel empowered to contribute, and accountability underpins our actions.
When culture, systems and purpose are aligned, we unlock stronger outcomes for our people and the patients we serve.
Rebecca Jennings
Talent Lead
Joined UCB in 2025
"As the Legal Counsel of our global organisation, I believe that true leadership is about fostering a culture of integrity, accountability, and innovation. By aligning our legal strategies with the company’s vision, we not only protect our business but also empower our teams to navigate challenges with confidence and drive sustainable growth across borders."
Grace Tian
Legal Lead
Joined UCB in 2020
AU-OT-2400019. March 2026.